Buspirone treatment of cannabis dependence: A randomized, placebo-controlled trial
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Background The purpose of this study was to evaluate the efficacy of buspirone, a partial 5-HT1A agonist, for treatment of cannabis dependence. Methods One hundred seventy-five cannabis-dependent adults were randomized to receive either up to 60 mg/day of buspirone (n=88) or placebo (n=87) for twelve weeks combined with a brief motivational enhancement therapy intervention and contingency management to encourage study retention. Cannabis use outcomes were assessed via weekly urine cannabinoid tests; secondary outcomes included cannabis craving, cannabis withdrawal symptoms, and clinician ratings of symptom severity. Results Participants in both groups reported reduced cannabis craving over the course of the study; however, buspirone provided no advantage over placebo in reducing cannabis use. Significant gender by treatment interaction were observed, with women randomized to buspirone having fewer negative urine cannabinoid tests than women randomized to placebo (p=0.007), and men randomized to buspirone having significantly lower creatinine adjusted cannabinoid levels as compared to those randomized to placebo (p=0.023). An evaluation of serotonin allelic variations did not find an association with buspirone treatment response. Conclusions Buspirone was not more efficacious than placebo in reducing cannabis use. Important gender differences were noted, with women having worse cannabis use outcomes with buspirone treatment. Considerations for future medication trials in this challenging population are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Anthony, J. C., Warner, L. A., & Kessler, R. C. (1994) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.2.3.244 · Cited by 1,341
Ensuring balanced distribution of prognostic factors in treatment outcome research.
Stout, R. L., Wirtz, P. W., Carbonari, J. P., & Del Boca, F. K. (1994) · Journal of Studies on Alcohol, Supplement · doi:10.15288/jsas.1994.s12.70 · Cited by 461 · cited 1×
“Stratified randomization (Stout et al., 1994) was used to determine treatment assignment.”
MethodCannabis use disorders in the USA: prevalence, correlates and co-morbidity
STINSON, F. S., RUAN, W. J., PICKERING, R., & GRANT, B. F. (2006) · Psychological Medicine · doi:10.1017/s0033291706008361 · Cited by 422 · cited 3×
“This low endorsement of general anxiety symptoms is somewhat unexpected given the reported high comorbidity of cannabis use and anxiety disorders (Stinson et al., 2006); however, it may be reflective of excluding individuals requiring treatment with psychoactive medications or meeting criteria for…”
BackgroundSerotonin-1A receptor imaging in recurrent depression: replication and literature review
Drevets, W. C., Thase, M. E., Moses-Kolko, E. L., Price, J., Frank, E., Kupfer, D. J., & Mathis, C. (2007) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2007.06.008 · Cited by 399 · cited 2×
“A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript decreased 5-HT1A binding potential in depressed patients compared to controls (Drevets et al, 2007).”
BackgroundMarijuana withdrawal among adults seeking treatment for marijuana dependence.
Budney, A. J., Novy, P. L., & Hughes, J. R. (1999) · Addiction · doi:10.1046/j.1360-0443.1999.94913114.x · Cited by 348 · cited 2×
“Further, the anxiolytic effects of buspirone may be helpful in preventing relapse to cannabis use, as high anxiety scores have been correlated with increased cannabis withdrawal (Budney et al., 1999), anxiety has been shown to be related to use of cannabis to cope with negative affect (Buckner et al.”
BackgroundA Double-Blind Randomized Controlled Trial of N -Acetylcysteine in Cannabis-Dependent Adolescents
Gray, K. M., Carpenter, M. J., Baker, N. L., DeSantis, S. M., Kryway, E., Hartwell, K. J., McRae-Clark, A. L., & Brady, K. T. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12010055 · Cited by 306
Self-citationMason, B. J., Crean, R., Goodell, V., Light, J. M., Quello, S., Shadan, F., Buffkins, K., Kyle, M., Adusumalli, M., Begovic, A., et al. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.14 · Cited by 242 · cited 1×
“In particular, the role that medications may play in the treatment of cannabis use disorders has become an active area of research (Levin et al., 2011; Gray et al., 2012; Mason et al., 2012).”
BackgroundLevin, F. R., Mariani, J. J., Brooks, D. J., Pavlicova, M., Cheng, W., & Nunes, E. V. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.12.010 · Cited by 232 · cited 2×
“In particular, the role that medications may play in the treatment of cannabis use disorders has become an active area of research (Levin et al., 2011; Gray et al., 2012; Mason et al., 2012).”
BackgroundReliability and validity of a short form of the Marijuana Craving Questionnaire
Heishman, S. J., Evans, R. J., Singleton, E. G., Levin, K. H., Copersino, M. L., & Gorelick, D. A. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.12.010 · Cited by 212
Serotonin-1A autoreceptor binding in the dorsal raphe nucleus of depressed suicides
Boldrini, M., Underwood, M. D., Mann, J. J., & Arango, V. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2007.05.004 · Cited by 190 · cited 2×
“Boldrini et al. (2008) found an ncrease in 5-HT1A autoreceptors in postmortem brain samples of epressed suicidepatients comparedwithnormal controls.”
Background
Cited by
Sex and gender differences in substance use disorders
McHugh, R. K., Votaw, V. R., Sugarman, D. E., & Greenfield, S. F. (2018) · Clinical Psychology Review · doi:10.1016/j.cpr.2017.10.012 · Cited by 1,076
Sex-Dependent Effects of Cannabis and Cannabinoids: A Translational Perspective
Cooper, Z. D., & Craft, R. M. (2018) · Neuropsychopharmacology · doi:10.1038/npp.2017.140 · Cited by 350
Treatment of Cannabis Use Disorder: Current Science and Future Outlook
Sherman, B. J., & McRae‐Clark, A. L. (2016) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1747 · Cited by 208
Self-citationPharmacotherapies for cannabis dependence.
Marshall, K., Gowing, L., Ali, R., & Le Foll, B. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008940.pub2 · Cited by 156
Pharmacotherapies for cannabis dependence
Nielsen, S., Gowing, L., Sabioni, P., & Le Foll, B. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008940.pub3 · Cited by 96
Metadata
- Authors
- McRae-Clark, A. L., Baker, N. L., Gray, K. M., Killeen, T. K., Wagner, A. M., Brady, K. T., DeVane, C. L., & Norton, J.
- Venue
- Drug and Alcohol Dependence
- Publisher
- Elsevier BV
- Published
- 2015-11
- Volume
- 156
- Pages
- 29-37
- ISSN
- 0376-8716 (ISSN-L)
- OpenAlex
- W2163434838
- Cited by
- 72
- References
- 16
- FWCI
- 5.08
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Buspirone treatment of cannabis dependence: A randomized, placebo-controlled trial. https://app.cochat.ai/papers/10.1016/j.drugalcdep.2015.08.013
- The paper
- McRae-Clark, A. L., Baker, N. L., Gray, K. M., Killeen, T. K., Wagner, A. M., Brady, K. T., DeVane, C. L., & Norton, J. (2015). Buspirone treatment of cannabis dependence: A randomized, placebo-controlled trial. Drug and Alcohol Dependence. https://doi.org/10.1016/j.drugalcdep.2015.08.013
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.